CoChat

Alu Elements in ANRIL Non-Coding RNA at Chromosome 9p21 Modulate Atherogenic Cell Functions through Trans-Regulation of Gene Networks

Open access

The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.

Abstract

The chromosome 9p21 (Chr9p21) locus of coronary artery disease has been identified in the first surge of genome-wide association and is the strongest genetic factor of atherosclerosis known today. Chr9p21 encodes the long non-coding RNA (ncRNA) antisense non-coding RNA in the INK4 locus (ANRIL). ANRIL expression is associated with the Chr9p21 genotype and correlated with atherosclerosis severity. Here, we report on the molecular mechanisms through which ANRIL regulates target-genes in trans, leading to increased cell proliferation, increased cell adhesion and decreased apoptosis, which are all essential mechanisms of atherogenesis. Importantly, trans-regulation was dependent on Alu motifs, which marked the promoters of ANRIL target genes and were mirrored in ANRIL RNA transcripts. ANRIL bound Polycomb group proteins that were highly enriched in the proximity of Alu motifs across the genome and were recruited to promoters of target genes upon ANRIL over-expression. The functional relevance of Alu motifs in ANRIL was confirmed by deletion and mutagenesis, reversing trans-regulation and atherogenic cell functions. ANRIL-regulated networks were confirmed in 2280 individuals with and without coronary artery disease and functionally validated in primary cells from patients carrying the Chr9p21 risk allele. Our study provides a molecular mechanism for pro-atherogenic effects of ANRIL at Chr9p21 and suggests a novel role for Alu elements in epigenetic gene regulation by long ncRNAs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1003588

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Annotated ANRIL transcripts in the Chr9p21 region, transcript structure and association of ANRIL isoforms with Chr9p21 genotype. (A) Chr9p21 haplotype structure (HapMap CEU, r2) and core atherosclerosis region (between rs12555547 and rs1333050). (B) Exons of initially discovered ANRIL transcripts and their relative position in the Chr9p21 region. *A full list of currently annotated ANRIL isoforms is given in Figure S1B. (C) ANRIL transcripts identified by RACE and PCR amplification (L1-L17). 4 major isoform groups with 4 distinct transcriptions ends were identified. Frequency of exon occurrence/isoform group is color-coded and given in %. ANRIL1-4 denote highly expressed consensus transcripts harbouring exons found in >50% transcripts of the respective isoform group (red). Dotted lines indicate positions of transcript-specific qRT-PCR assays. (D) Study design of ANRIL expression and association with Chr9p21. (E) Association of ANRIL isoforms with Chr9p21 in human PBMC, whole blood and vascular tissue (effect, % change/risk allele defined by rs10757274, rs2383206, rs2383297, and rs10757278).
Figure 1 Annotated ANRIL transcripts in the Chr9p21 region, transcript structure and association of ANRIL isoforms with Chr9p21 genotype. (A) Chr9p21 haplotype structure (HapMap CEU, r2) and core atherosclerosis region (between rs12555547 and rs1333050). (B) Exons of initially discovered ANRIL transcripts and their relative position in the Chr9p21 region. *A full list of currently annotated ANRIL isoforms is given in Figure S1B. (C) ANRIL transcripts identified by RACE and PCR amplification (L1-L17). 4 major isoform groups with 4 distinct transcriptions ends were identified. Frequency of exon occurrence/isoform group is color-coded and given in %. ANRIL1-4 denote highly expressed consensus transcripts harbouring exons found in >50% transcripts of the respective isoform group (red). Dotted lines indicate positions of transcript-specific qRT-PCR assays. (D) Study design of ANRIL expression and association with Chr9p21. (E) Association of ANRIL isoforms with Chr9p21 in human PBMC, whole blood and vascular tissue (effect, % change/risk allele defined by rs10757274, rs2383206, rs2383297, and rs10757278).CC BY · PubMed Central
Figure 2 ANRIL regulates gene expression in trans and affects cell adhesion, metabolic activity, proliferation, and apoptosis. (A) Consensus transcripts of 4 ANRIL isoform groups identified by RACE and PCR (Figure S1). Dotted lines indicate positions of transcript-specific qRT-PCR assays. (B) RT-PCR confirmation of ANRIL over-expression in stable ANRIL1-4 cell lines. 3–4 cell lines per ANRIL isoform were established, no effect on house-keeping gene expression was found (beta-actin (BA); glyceraldehyde-3-phosphate dehydrogenase (GAPDH)). (C) Heatmap of ANRIL trans-regulated transcripts corresponding to panel B. Transcripts with average down- (<0.5-fold, red) and up- (>2-fold, green) regulation relative to vector control are shown. (D–F) Adhesion of ANRIL over-expressing cell lines to PBS-, Matrigel-, and collagen-coated wells (P<0.01 for comparison of ANRIL1, 2, 3, 4 vs. vector control). (G–I) Cell proliferation and metabolic activity determined by (G) absolute cell numbers, (*/# P<0.05 for ANRIL2 and ANRIL4 vs. vector control), (H) glucose utilisation, and (I) viability assay. (J–L) Apoptosis determined by (J) AnnexinV-positive cells, (K) caspase activity, and (L) caspase-3 staining. (H–K) P<0.05 for ANRIL2 and ANRIL4 vs. vector control. (M–O) Reversal of effects by RNAi against ANRIL (*P<0.05; SCR- scrambled control). (D–K) At least triplicate measurements per pool of 3–4 biological replicates were performed. For details on experimental setup and P-values please see Table S3. (M–O) n = 3/group. Validation of siRNA knock-down is shown in Figure S6. Error bars indicate s.e.m.
Figure 2 ANRIL regulates gene expression in trans and affects cell adhesion, metabolic activity, proliferation, and apoptosis. (A) Consensus transcripts of 4 ANRIL isoform groups identified by RACE and PCR (Figure S1). Dotted lines indicate positions of transcript-specific qRT-PCR assays. (B) RT-PCR confirmation of ANRIL over-expression in stable ANRIL1-4 cell lines. 3–4 cell lines per ANRIL isoform were established, no effect on house-keeping gene expression was found (beta-actin (BA); glyceraldehyde-3-phosphate dehydrogenase (GAPDH)). (C) Heatmap of ANRIL trans-regulated transcripts corresponding to panel B. Transcripts with average down- (<0.5-fold, red) and up- (>2-fold, green) regulation relative to vector control are shown. (D–F) Adhesion of ANRIL over-expressing cell lines to PBS-, Matrigel-, and collagen-coated wells (P<0.01 for comparison of ANRIL1, 2, 3, 4 vs. vector control). (G–I) Cell proliferation and metabolic activity determined by (G) absolute cell numbers, (*/# P<0.05 for ANRIL2 and ANRIL4 vs. vector control), (H) glucose utilisation, and (I) viability assay. (J–L) Apoptosis determined by (J) AnnexinV-positive cells, (K) caspase activity, and (L) caspase-3 staining. (H–K) P<0.05 for ANRIL2 and ANRIL4 vs. vector control. (M–O) Reversal of effects by RNAi against ANRIL (*P<0.05; SCR- scrambled control). (D–K) At least triplicate measurements per pool of 3–4 biological replicates were performed. For details on experimental setup and P-values please see Table S3. (M–O) n = 3/group. Validation of siRNA knock-down is shown in Figure S6. Error bars indicate s.e.m.CC BY · PubMed Central
Figure 3 ANRIL binds to PRC1 and 2 proteins and recruits CBX7 and SUZ12 to promoters of target genes. (A, B) RNA immunoprecipitation (RIP) followed by qRT-PCR demonstrating ANRIL binding to PRC but not to CoREST/REST proteins in (A) ANRIL2 and (B) ANRIL4 cells. Copies of ANRIL relative to input control are given in (A) blue and (B) red, nuclear ncRNA U1 (white) was used as negative control. rIgG/mIgG/gIgG- rabbit/mouse/goat IgG controls. Error bars indicate s.e.m. (C,D) SUZ12 binding in promoters of ANRIL up-(green), down-(red), and not (black) regulated genes in (C) vector control cell line and (D) in BGO3 cells (GSM602674). TSS- transcription start site. (E, F) Effect of ANRIL over-expression on (E) SUZ12 and (F) CBX7 binding in promoters of up-regulated genes (vector control- dotted line vs. ANRIL2- straight line). (G) Reversal of ANRIL trans-regulation by RNAi against SUZ12 and CBX7 in ANRIL2 cells. SCR- scrambled siRNA control.
Figure 3 ANRIL binds to PRC1 and 2 proteins and recruits CBX7 and SUZ12 to promoters of target genes. (A, B) RNA immunoprecipitation (RIP) followed by qRT-PCR demonstrating ANRIL binding to PRC but not to CoREST/REST proteins in (A) ANRIL2 and (B) ANRIL4 cells. Copies of ANRIL relative to input control are given in (A) blue and (B) red, nuclear ncRNA U1 (white) was used as negative control. rIgG/mIgG/gIgG- rabbit/mouse/goat IgG controls. Error bars indicate s.e.m. (C,D) SUZ12 binding in promoters of ANRIL up-(green), down-(red), and not (black) regulated genes in (C) vector control cell line and (D) in BGO3 cells (GSM602674). TSS- transcription start site. (E, F) Effect of ANRIL over-expression on (E) SUZ12 and (F) CBX7 binding in promoters of up-regulated genes (vector control- dotted line vs. ANRIL2- straight line). (G) Reversal of ANRIL trans-regulation by RNAi against SUZ12 and CBX7 in ANRIL2 cells. SCR- scrambled siRNA control.CC BY · PubMed Central
Figure 4 Identification of Alu motifs in promoters of ANRIL trans-regulated genes and ANRIL RNA and their spatial relation to PcG protein binding. (A) DNA motif in promoters (5 kb) of trans-regulated genes representing an Alu-DEIN repeat [33]. (B) Number of Alu motifs in promoters of trans- and not regulated transcripts (n per 5 kb). (C) ChIP-seq enrichment of SUZ12 and CBX7 binding distal to Alu motif, demonstrating a specific spatial relation of motif occurrence to PcG protein binding. RPM- reads per million mapped reads, CTR- random DNA control sequence. (D) Motif-associated SUZ12 signal peaks in an independent data set from BGO3 cells. The actual signal peak only becomes apparent, if a multiple matching policy is adopted. (E) Using a strict unique-matches only policy, a substantial signal reduction is seen downstream of the motif. Please note differences in y-axis scaling in (D, E). (F) Secondary RNA structure prediction for ANRIL2 using the Vienna RNA package [58]. Within the minimum free energy structure, the Alu-DEIN motif is located in a stem-loop structure (arrow). (G) RIP demonstrating ANRIL binding to histone H3 (H3) and trimethylated lysine 27 of histone 3 (H3K27me3) in ANRIL2 (blue) and ANRIL4 (red) cells. U1 was used as negative control. mIgG/rIgG- mouse/rabbit IgG control. Error bars indicate s.e.m.
Figure 4 Identification of Alu motifs in promoters of ANRIL trans-regulated genes and ANRIL RNA and their spatial relation to PcG protein binding. (A) DNA motif in promoters (5 kb) of trans-regulated genes representing an Alu-DEIN repeat [33]. (B) Number of Alu motifs in promoters of trans- and not regulated transcripts (n per 5 kb). (C) ChIP-seq enrichment of SUZ12 and CBX7 binding distal to Alu motif, demonstrating a specific spatial relation of motif occurrence to PcG protein binding. RPM- reads per million mapped reads, CTR- random DNA control sequence. (D) Motif-associated SUZ12 signal peaks in an independent data set from BGO3 cells. The actual signal peak only becomes apparent, if a multiple matching policy is adopted. (E) Using a strict unique-matches only policy, a substantial signal reduction is seen downstream of the motif. Please note differences in y-axis scaling in (D, E). (F) Secondary RNA structure prediction for ANRIL2 using the Vienna RNA package [58]. Within the minimum free energy structure, the Alu-DEIN motif is located in a stem-loop structure (arrow). (G) RIP demonstrating ANRIL binding to histone H3 (H3) and trimethylated lysine 27 of histone 3 (H3K27me3) in ANRIL2 (blue) and ANRIL4 (red) cells. U1 was used as negative control. mIgG/rIgG- mouse/rabbit IgG control. Error bars indicate s.e.m.CC BY · PubMed Central
Figure 5 Pivotal role for Alu motif in ANRIL RNA function. (A) Cell lines over-expressing variants of ANRIL2 (ANRIL2a, 2b, 2c) and ANRIL4 (ANRIL4a, 4b) devoid of Alu motif sequences highlighted by boxes. Validation of over-expression using qRT-PCR assays. (B) Reversal of up-regulation (TSC22D3) and (C) down-regulation (COL3A1) of ANRIL target-gene mRNA expression in ANRIL2a-2c and ANRIL4a,4b compared to ANRIL2 and ANRIL4. Reversal of (D) cell adhesion, (E) apoptosis, and (F) proliferation in cell lines over-expressing mutant ANRIL isoforms. (G) Stable cell lines containing mutated forms of the Alu motif in ANRIL2. Positions of nucleotide exchanges (0, 25%, 33%, and 100%) in the 48 base-pair Alu motif are indicated in red. (H,I) Reversal of trans-regulation in mutant cell lines compared to ANRIL2. (J) Cell adhesion, (K) apoptosis, and (L) proliferation in mutant cell lines. (B,C,H,I,F,L) 3–4 biological replicates/isoform.(D,E,J,K) quadruplicate measurements per pool of 2–3 biological replicates. Error bars indicate s.e.m.
Figure 5 Pivotal role for Alu motif in ANRIL RNA function. (A) Cell lines over-expressing variants of ANRIL2 (ANRIL2a, 2b, 2c) and ANRIL4 (ANRIL4a, 4b) devoid of Alu motif sequences highlighted by boxes. Validation of over-expression using qRT-PCR assays. (B) Reversal of up-regulation (TSC22D3) and (C) down-regulation (COL3A1) of ANRIL target-gene mRNA expression in ANRIL2a-2c and ANRIL4a,4b compared to ANRIL2 and ANRIL4. Reversal of (D) cell adhesion, (E) apoptosis, and (F) proliferation in cell lines over-expressing mutant ANRIL isoforms. (G) Stable cell lines containing mutated forms of the Alu motif in ANRIL2. Positions of nucleotide exchanges (0, 25%, 33%, and 100%) in the 48 base-pair Alu motif are indicated in red. (H,I) Reversal of trans-regulation in mutant cell lines compared to ANRIL2. (J) Cell adhesion, (K) apoptosis, and (L) proliferation in mutant cell lines. (B,C,H,I,F,L) 3–4 biological replicates/isoform.(D,E,J,K) quadruplicate measurements per pool of 2–3 biological replicates. Error bars indicate s.e.m.CC BY · PubMed Central
Figure 6 Validation of ANRIL-associated cellular effects in primary cells and schematic of molecular scaffolding by ANRIL. (A) PBMC from carriers of the Chr9p21 CAD-risk allele defined by rs10757274, rs2383206, rs2383297, and rs10757278 (n = 8) showed increased adhesion (P = 0.001) and (B) decreased apoptosis (P = 0.008) compared to cells of carriers of the protective allele (n = 8). (C) Schematic of molecular scaffolding by ANRIL mediated through potential chromatin-RNA interaction by Alu motifs.
Figure 6 Validation of ANRIL-associated cellular effects in primary cells and schematic of molecular scaffolding by ANRIL. (A) PBMC from carriers of the Chr9p21 CAD-risk allele defined by rs10757274, rs2383206, rs2383297, and rs10757278 (n = 8) showed increased adhesion (P = 0.001) and (B) decreased apoptosis (P = 0.008) compared to cells of carriers of the protective allele (n = 8). (C) Schematic of molecular scaffolding by ANRIL mediated through potential chromatin-RNA interaction by Alu motifs.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 403

Metadata

Authors
Holdt, L. M., Hoffmann, S., Sass, K., Langenberger, D., Scholz, M., Krohn, K., Finstermeier, K., Stahringer, A., Wilfert, W., Beutner, F., Gielen, S., Schuler, G., Gäbel, G., Bergert, H., Bechmann, I., Stadler, P. F., Thiery, J., & Teupser, D.
Affiliations
  • University Hospital Leipzig (DE)
  • Leipzig University (DE)
  • Technische Universität Dresden (DE)
  • Santa Fe Institute (US)
Corresponding author
Teupser, Daniel
Venue
PLoS Genetics
Published
2013-07-04
Volume
9
Issue
7
Pages
e1003588
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W1972104572
Cited by
397
References
62
Citations by year
2026: 14 · 2025: 13 · 2024: 12 · 2023: 18 · 2022: 36 · 2021: 33 · 2020: 42 · 2019: 38 · 2018: 40 · 2017: 43 · 2016: 37 · 2015: 41 · 2014: 27 · 2013: 3
FWCI
12.65
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Max Planck Institute for Plasma Physics (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • European Commission
  • Freistaat Sachsen
  • European Regional Development Fund
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
ANRIL, Alu elements, chromosome 9p21, long non-coding RNA, trans-regulation, atherosclerosis, coronary artery disease, Polycomb group proteins, epigenetic regulation, cell proliferation, cell adhesion, apoptosis, risk alleles
MeSH terms
Cell Adhesion, Chromosomes, Human, Pair 9, Coronary Artery Disease, Gene Expression Regulation, Humans, Apoptosis, Genetic Predisposition to Disease, Alu Elements, Polymorphism, Single Nucleotide, Epigenesis, Genetic, Cell Proliferation, Atherosclerosis, Gene Regulatory Networks, Genome-Wide Association Study, HEK293 Cells, RNA, Long Noncoding, Polycomb-Group Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.